Last Updated:
Access Report
Name Designation Appointment Date Status
Sarika Rai

Appointed as Director since January 2017

 Director 03-Jan-2017 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Rajnish Kant Rai

Appointed as Director since January 2017

 Director 03-Jan-2017 Current

People Timeline

Explore the timeline of key personnel in Broadspectrum Pharmaceuticals Private Limited's leadership journey.

Contact Details
  • Address H. No.52 Flant No. 9 Blk-1, 2Nd Floor Gulab Bagh, Uttam Nagar, Near Gupta Asso, Ciates, New Delhi Delhi, 110059, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 110059
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Broadspectrum Pharmaceuticals Private Limited?
You can contact Broadspectrum Pharmaceuticals Private Limited through their registered address at H. No.52 Flant No. 9 Blk-1, 2Nd Floor Gulab Bagh, Uttam Nagar, Near Gupta Asso, Ciates, New Delhi Delhi, 110059, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Broadspectrum Pharmaceuticals Private Limited?
The current directors of Broadspectrum Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • SARIKA RAI
  • RAJNISH KANT RAI
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available